Secondary Logo

Most Popular Articles

CYP2C9 variants as a risk modifier of NSAID-related gastrointestinal bleeding: a case–control study

Figueiras, Adolfo; Estany-Gestal, Ana; Aguirre, Carmelo; More

Pharmacogenetics and Genomics. 26(2):66-73, February 2016.

Characterization of ADME gene variation in 21 populations by exome sequencing

Hovelson, Daniel H.; Xue, Zhengyu; Zawistowski, Matthew; More

Pharmacogenetics and Genomics. 27(3):89-100, March 2017.

Assessment of provider-perceived barriers to clinical use of pharmacogenomics during participation in an institutional implementation study

Borden, Brittany A.; Galecki, Paige; Wellmann, Rebecca; More

Pharmacogenetics and Genomics. 29(2):31-38, February 2019.

Strong association between HLA-B*5801 and allopurinol-induced Stevens–Johnson syndrome and toxic epidermal necrolysis in a Thai population

Tassaneeyakul, Wichittra; Jantararoungtong, Thawinee; Chen, Pei; More

Pharmacogenetics and Genomics. 19(9):704-709, September 2009.

Genetic diversity of variants involved in drug response and metabolism in Sri Lankan populations: implications for clinical implementation of pharmacogenomics

Chan, Sze Ling; Samaranayake, Nilakshi; Ross, Colin J.D.; More

Pharmacogenetics and Genomics. 26(1):28-39, January 2016.

Utility of integrated pharmacogenomic testing to support the treatment of major depressive disorder in a psychiatric outpatient setting

Hall-Flavin, Daniel K.; Winner, Joel G.; Allen, Josiah D.; More

Pharmacogenetics and Genomics. 23(10):535-548, October 2013.

Pharmacogenetics-based population pharmacokinetic analysis of etravirine in HIV-1 infected individuals

Lubomirov, Rubin; Arab-Alameddine, Mona; Rotger, Margalida; More

Pharmacogenetics and Genomics. 23(1):9-18, January 2013.

Adverse drug reactions to azathioprine therapy are associated with polymorphism in the gene encoding inosine triphosphate pyrophosphatase (ITPase)

Marinaki, Anthony M; Ansari, Azhar; Duley, John A; More

Pharmacogenetics. 14(3):181-187, March 2004.

The common Arg389gly ADRB1 polymorphism affects heart rate response to the ultra-short-acting β1 adrenergic receptor antagonist esmolol in healthy individuals

Muszkat, Mordechai; Hoofien, Assaf; Orlanski-Meyer, Esther; More

Pharmacogenetics and Genomics. 23(1):25-28, January 2013.

Pharmacogenomic characterization of gemcitabine response – a framework for data integration to enable personalized medicine

Harris, Michael; Bhuvaneshwar, Krithika; Natarajan, Thanemozhi; More

Pharmacogenetics and Genomics. 24(2):81-93, February 2014.

A genetic variant in NRP1 is associated with worse response to ranibizumab treatment in neovascular age-related macular degeneration

Lorés-Motta, Laura; van Asten, Freekje; Muether, Philipp S.; More

Pharmacogenetics and Genomics. 26(1):20-27, January 2016.

Role of alcohol and genetic polymorphisms of CYP2E1 and ALDH2 in breast cancer development

Choi, Ji-Yeob; Abel, Josef; Neuhaus, Thomas; More

Pharmacogenetics. 13(2):67-72, February 2003.

Genetic polymorphisms of cytochrome P450 2A6 in a case–control study on lung cancer in a French population

Loriot, Marie-Anne; Rebuissou, Sandra; Oscarson, Mikael; More

Pharmacogenetics. 11(1):39-44, February 2001.

Multiphenotype association study of patients randomized to initiate antiretroviral regimens in AIDS Clinical Trials Group protocol A5202

Verma, Anurag; Bradford, Yuki; Verma, Shefali S.; More

Pharmacogenetics and Genomics. 27(3):101-111, March 2017.

CYP2D6 function moderates the pharmacokinetics and pharmacodynamics of 3,4-methylene-dioxymethamphetamine in a controlled study in healthy individuals

Schmid, Yasmin; Vizeli, Patrick; Hysek, Cédric M.; More

Pharmacogenetics and Genomics. 26(8):397-401, August 2016.

Analytical validity of a genotyping assay for use with personalized antihypertensive and chronic kidney disease therapy

Collins, Kimberly S.; Pratt, Victoria M.; Stansberry, Wesley M.; More

Pharmacogenetics and Genomics. 29(1):18-22, January 2019.

The combination of mitochondrial low enzyme-activity aldehyde dehydrogenase 2 allele and superoxide dismutase 2 genotypes increases the risk of hypertension in relation to alcohol consumption

Nakagawa, Takehiro; Kajiwara, Ayami; Saruwatari, Junji; More

Pharmacogenetics and Genomics. 23(1):34-37, January 2013.

The relationship of polymorphisms in ABCC2 and SLCO1B3 with docetaxel pharmacokinetics and neutropenia: CALGB 60805 (Alliance)

Lewis, Lionel D.; Miller, Antonius A.; Owzar, Kouros; More

Pharmacogenetics and Genomics. 23(1):29-33, January 2013.

The functional G143E variant of carboxylesterase 1 is associated with increased clopidogrel active metabolite levels and greater clopidogrel response

Lewis, Joshua P.; Horenstein, Richard B.; Ryan, Kathleen; More

Pharmacogenetics and Genomics. 23(1):1-8, January 2013.

Progesterone receptor variant increases ovarian cancer risk in BRCA1 and BRCA2 mutation carriers who were never exposed to oral contraceptives

Runnebaum, Ingo B.; Wang-Gohrke, Shan; Vesprini, Danny; More

Pharmacogenetics. 11(7):635-638, October 2001.

ABCB1 C3435T and G2677T/A polymorphism decreased the risk for steroid-induced osteonecrosis of the femoral head after kidney transplantation

Asano, Takeshi; Takahashi, Kenji A; Fujioka, Mikihiro; More

Pharmacogenetics. 13(11):675-682, November 2003.

The genetic determinants of the CYP3A5 polymorphism

Hustert, Elisabeth; Haberl, Michael; Burk, Oliver; More

Pharmacogenetics. 11(9):773-779, December 2001.

Single-nucleotide polymorphisms in P450 oxidoreductase and peroxisome proliferator-activated receptor-α are associated with the development of new-onset diabetes after transplantation in kidney transplant recipients treated with tacrolimus

Elens, Laure; Sombogaard, Ferdi; Hesselink, Dennis A.; More

Pharmacogenetics and Genomics. 23(12):649-657, December 2013.

Allele and genotype frequencies of polymorphic cytochromes P4502D6, 2C19 and 2E1 in Aborigines from Western Australia

Griese, Ernst-Ulrich; Ilett, Kenneth F.; Kitteringham, Neil R.; More

Pharmacogenetics. 11(1):69-76, February 2001.

Haplotype analysis of ABCB1/MDR1 blocks in a Japanese population reveals genotype-dependent renal clearance of irinotecan

Sai, Kimie; Kaniwa, Nahoko; Itoda, Masaya; More

Pharmacogenetics. 13(12):741-757, December 2003.

Influence of the CYP3A4/5 genetic score and ABCB1 polymorphisms on tacrolimus exposure and renal function in Brazilian kidney transplant patients

Genvigir, Fabiana D.V.; Salgado, Patricia C.; Felipe, Claudia R.; More

Pharmacogenetics and Genomics. 26(10):462-472, October 2016.

A European study of HLA-B in Stevens–Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs

Lonjou, Christine; Borot, Nicolas; Sekula, Peggy; More

Pharmacogenetics and Genomics. 18(2):99-107, February 2008.

Sympathoneural and adrenomedullary functional effects of α2C-adrenoreceptor gene polymorphism in healthy humans

Neumeister, Alexander; Charney, Dennis S.; Belfer, Inna; More

Pharmacogenetics and Genomics. 15(3):143-149, March 2005.

A comprehensive analysis of phase I and phase II metabolism gene polymorphisms and risk of colorectal cancer

Landi, Stefano; Gemignani, Federica; Moreno, Victor; More

Pharmacogenetics and Genomics. 15(8):535-546, August 2005.